These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29866607)

  • 21. Alpha-Fetoprotein Slope >7.5 ng/mL per Month Predicts Microvascular Invasion and Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma.
    Giard JM; Mehta N; Dodge JL; Roberts JP; Yao FY
    Transplantation; 2018 May; 102(5):816-822. PubMed ID: 29505494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three-dimensional tumor volume and serum alpha-fetoprotein are predictors of hepatocellular carcinoma recurrence after liver transplantation: refined selection criteria.
    Kashkoush S; El Moghazy W; Kawahara T; Gala-Lopez B; Toso C; Kneteman NM
    Clin Transplant; 2014 Jun; 28(6):728-36. PubMed ID: 24708263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biologic markers as predictors for liver transplant outcome.
    Freeman RB
    Am J Transplant; 2010 Jan; 10(1):10-1. PubMed ID: 19951278
    [No Abstract]   [Full Text] [Related]  

  • 24. Utility-based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha-fetoprotein model as a survival predictor.
    Vitale A; Farinati F; Burra P; Trevisani F; Giannini EG; Ciccarese F; Piscaglia F; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Cabibbo G; Felder M; Sacco R; Morisco F; Missale G; Foschi FG; Gasbarrini A; Svegliati Baroni G; Virdone R; Chiaramonte M; Spolverato G; Cillo U;
    Liver Transpl; 2015 Oct; 21(10):1250-8. PubMed ID: 26183802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Appropriate liver resection type for patients with the American joint committee on cancer classification T1 and T2 hepatocellular carcinoma.
    Hsieh CB; Chung KP; Chu CM; Yu JC; Hsieh HF; Chu HC; Yu CY; Chen TW
    Eur J Surg Oncol; 2011 Jun; 37(6):497-504. PubMed ID: 21450438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A long-term survival case of hepatocellular carcinoma recurrence after the patient received a living donor liver transplantation treated by combined modality therapy].
    Hama N; Marubashi S; Dono K; Kobayashi S; Kim C; Asaoka T; Takeda Y; Nagano H; Umeshita K; Monden M; Doki Y; Mori M
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2092-5. PubMed ID: 19106534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of absolute serum α-fetoprotein levels in liver transplant for hepatocellular cancer.
    Mailey B; Artinyan A; Khalili J; Denitz J; Sanchez-Luege N; Sun CL; Bhatia S; Nissen N; Colquhoun SD; Kim J
    Arch Surg; 2011 Jan; 146(1):26-33. PubMed ID: 21242442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver transplantation for hepatocellular carcinoma using extended criteria donor grafts.
    Sotiropoulos GC; Tagkalos E; Fouzas I; Vernadakis S; Mathé Z; Treckmann J; Paul A
    Transplant Proc; 2012 Nov; 44(9):2730-3. PubMed ID: 23146507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time of hepatocellular carcinoma recurrence after liver resection and alpha-fetoprotein are important prognostic factors for salvage liver transplantation.
    Lee S; Hyuck David Kwon C; Man Kim J; Joh JW; Woon Paik S; Kim BW; Wang HJ; Lee KW; Suh KS; Lee SK
    Liver Transpl; 2014 Sep; 20(9):1057-63. PubMed ID: 24862741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HCC in living donor liver transplantation: can we expand the Milan criteria?
    Kwon CH; Kim DJ; Han YS; Park JB; Choi GS; Kim SJ; Joh JW; Lee SK
    Dig Dis; 2007; 25(4):313-9. PubMed ID: 17960066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative investigation and indication for operation in hepatocellular carcinoma.
    Riordan SM; Williams R
    J Hepatobiliary Pancreat Surg; 1998; 5(1):1-6. PubMed ID: 9683746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver transplantation for hepatocellular carcinoma after down staging with sorafenib: a monocentric case-matched series.
    Palen A; Grégoire E; Chopinet S; Borentain P; Gerolami R; Hardwigsen J
    J Gastrointestin Liver Dis; 2020 Mar; 29(1):120-121. PubMed ID: 32176754
    [No Abstract]   [Full Text] [Related]  

  • 33. Patient Selection by Tumor Markers in Liver Transplantation for Advanced Hepatocellular Carcinoma.
    Lee HW; Song GW; Lee SG; Kim JM; Joh JW; Han DH; Kim SI; Kim SH; Kim DS; Cho JY; Suh KS
    Liver Transpl; 2018 Sep; 24(9):1243-1251. PubMed ID: 29575509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Novel Prognostic Index in Patients With Hepatocellular Cancer Waiting for Liver Transplantation: Time-Radiological-response-Alpha-fetoprotein-INflammation (TRAIN) Score.
    Lai Q; Nicolini D; Inostroza Nunez M; Iesari S; Goffette P; Agostini A; Giovagnoni A; Vivarelli M; Lerut J
    Ann Surg; 2016 Nov; 264(5):787-796. PubMed ID: 27429025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver transplantation for hepatocellular carcinoma in the MELD era: leading roles of MELD score, AFP level, and recipient age as predictors of survival.
    Sotiropoulos GC; Molmenti EP; Lang H
    Dig Dis Sci; 2009 Apr; 54(4):917. PubMed ID: 19156522
    [No Abstract]   [Full Text] [Related]  

  • 36. Incorporating AFP-L3 and DCP in selecting patients with hepatocellular carcinoma for liver transplantation: What are the optimal criteria?
    Sha M; Cao J; Xia Q
    J Hepatol; 2024 Apr; 80(4):e171-e172. PubMed ID: 37821020
    [No Abstract]   [Full Text] [Related]  

  • 37. Orthotopic liver transplantation for preoperative early-stage hepatocellular carcinoma.
    Tan CK; Gores GJ; Steers JL; Porayko MK; Hay JE; Rakela J; Wiesner RH; Krom RA
    Mayo Clin Proc; 1994 Jun; 69(6):509-14. PubMed ID: 7514702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Living donor liver transplantation for hepatocellular carcinoma.
    Isik B; Ince V; Karabulut K; Kayaalp C; Yilmaz S
    Transplant Proc; 2012; 44(6):1713-6. PubMed ID: 22841251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AFP and hepatoma staging.
    Wiwanitkit V
    Eur J Surg Oncol; 2010 Oct; 36(10):1015; author reply 1016. PubMed ID: 20708370
    [No Abstract]   [Full Text] [Related]  

  • 40. Analysis of the risk factors of untransplantable recurrence after primary curative resection for patients with hepatocellular carcinoma.
    Ho CM; Wu CY; Lee PH; Lai HS; Ho MC; Wu YM; Hu RH
    Ann Surg Oncol; 2013 Aug; 20(8):2526-33. PubMed ID: 23504121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.